Denise C. Connolly

Activation of cancer-specific gene expression by the survivin promoter.

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Focus on epithelial ovarian cancer.

Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation.

Pathology of Ovarian Neoplasms in Genetically Modified Mice.

Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer.

Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.

Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.

RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.

Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer.

Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.

NEDD9 promotes oncogenic signaling in mammary tumor development.

Animal models of ovarian cancer.

Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.

Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.

Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents.

Development of a syngeneic mouse model of epithelial ovarian cancer.

Miscommunication involving 'standard care'. Response to protocol review scenario: specify all medications.

Xenograft and transgenic mouse models of epithelial ovarian cancer and non-invasive imaging modalities to monitor ovarian tumor growth in situ: applications in evaluating novel therapeutic agents.